ClinicalTrials.Veeva

Find clinical trials for Lymphoma in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Charlotte, NC, USA:

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...

Enrolling
Hodgkin Lymphoma
Drug: Etoposide
Drug: DTIC

Phase 2

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma...

Enrolling
Lymphoma
Solid Tumors
Drug: Chemotherapy
Drug: Eflapegrastim

Phase 2

Spectrum Pharmaceuticals
Spectrum Pharmaceuticals

Charlotte, North Carolina, United States and 3 other locations

017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....

Active, not recruiting
Follicular Lymphoma
Mantle-cell Lymphoma
Biological: JCAR017 (lisocabtagene maraleucel) single-dose schedule
Biological: JCAR017 (lisocabtagene maraleucel) 2-dose schedule

Phase 1

Juno Therapeutics

Charlotte, North Carolina, United States and 13 other locations

dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...

Enrolling
Mantle Cell Lymphoma
Relapsed Mantle Cell Lymphoma
Drug: BGB-11417

Phase 1, Phase 2

BeiGene
BeiGene

Charlotte, North Carolina, United States and 95 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: brentuximab vedotin
Drug: bleomycin

Phase 3

Takeda
Takeda

Charlotte, North Carolina, United States and 215 other locations

with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:To improve the event-free surv...

Active, not recruiting
Acute Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Drug: Asparaginase Erwinia chrysanthemi (recombinant)-rywn
Drug: Thioguanine

Phase 2, Phase 3

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

with various types of blood cancers:relapsed or refractory (R/R) lymphomamultiple myelomanewly diagnosed acute myeloid leukemia (AML).This t...

Active, not recruiting
Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Dexamethasone
Drug: Venetoclax

Phase 1

Pfizer
Pfizer

Charlotte, North Carolina, United States and 61 other locations

T cells, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.The study will consist of 2 parts: dose-escalation (Part A) and...

Active, not recruiting
Agressive Lymphoma
Diffuse-large B-cell Lymphoma (DLBCL)
Biological: CC-97540

Phase 1

Juno Therapeutics

Charlotte, North Carolina, United States and 13 other locations

This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...

Active, not recruiting
Mantle-Cell Lymphoma
Drug: Ibrutinib
Drug: Venetoclax

Phase 3

Pharmacyclics
Pharmacyclics

Charlotte, North Carolina, United States and 119 other locations

dose escalation and expansion clinical trial to evaluate the safety, tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas...

Active, not recruiting
Lymphoma
Drug: HMPL-689

Phase 1

HUTCHMED
HUTCHMED

Charlotte, North Carolina, United States and 26 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems